CA2451268A1 - Ligands alpha2delta pour le traitement de la fibromyalgie et d'autres troubles - Google Patents

Ligands alpha2delta pour le traitement de la fibromyalgie et d'autres troubles Download PDF

Info

Publication number
CA2451268A1
CA2451268A1 CA 2451268 CA2451268A CA2451268A1 CA 2451268 A1 CA2451268 A1 CA 2451268A1 CA 2451268 CA2451268 CA 2451268 CA 2451268 A CA2451268 A CA 2451268A CA 2451268 A1 CA2451268 A1 CA 2451268A1
Authority
CA
Canada
Prior art keywords
disorder
pharmaceutically acceptable
sleep
treatment
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2451268
Other languages
English (en)
Inventor
Charles Price Taylor, Jr.
Andrew John Thorpe
Fong Wang
David Juergen Wustrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of CA2451268A1 publication Critical patent/CA2451268A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2451268 2003-06-27 2003-11-27 Ligands alpha2delta pour le traitement de la fibromyalgie et d'autres troubles Abandoned CA2451268A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48348203P 2003-06-27 2003-06-27
US60/483,482 2003-06-27

Publications (1)

Publication Number Publication Date
CA2451268A1 true CA2451268A1 (fr) 2004-12-27

Family

ID=34061960

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2451268 Abandoned CA2451268A1 (fr) 2003-06-27 2003-11-27 Ligands alpha2delta pour le traitement de la fibromyalgie et d'autres troubles

Country Status (1)

Country Link
CA (1) CA2451268A1 (fr)

Similar Documents

Publication Publication Date Title
US20070238749A1 (en) Alpha2delta ligands for the treatment of fibromyalgia and other disorders
ZA200504475B (en) Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders.
AU2006294645B2 (en) Milnacipran for the long-term treatment of fibromyalgia syndrome
ES2433080T3 (es) Inhibidores selectivos de la recaptación de norepinefrina-serotonina para el tratamiento del síndrome de fibromialgia, síndrome de fatiga crónica y dolor
AU2018272819A1 (en) Treatment of depressive disorders
TWI250872B (en) Carbamate compounds for use in preventing or treating bipolar disorder
ES2769780T3 (es) Tratamientos novedosos para los trastornos de atención y cognitivos y para la demencia asociada a un trastorno neurodegenerativo
JP2009539942A (ja) ビフェプルノックス及びｌ−ｄｏｐａを含む組み合わせ製剤
JP2002356445A (ja) 多発性硬化症（ｍｓ）、他の脱髄症状ならびに末梢神経障害、特に有痛の神経障害および糖尿病性神経障害の多剤併用治療
CA2451268A1 (fr) Ligands alpha2delta pour le traitement de la fibromyalgie et d'autres troubles
US7915262B2 (en) Combination preparations comprising SLV308 and a dopamine agonist
US20040006073A1 (en) Method of treating attention deficit hyperactivity disorder
JP2009539941A (ja) Ｓｌｖ３０８およびｌ−ｄｏｐａを含んでなる組み合わせ製剤
AU2012203789B2 (en) Milnacipran for the long-term treatment of fibromyalgia syndrome
TW200813038A (en) Combination preparations comprising SLV308 and L-DOPA

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead